Generics Drugs Market Research Reports & Industry Analysis
The Federal Drug Administration (FDA) does not allow a generic firm to duplicate exactly the brand name formula. The generic manufacturer must alter the ingredients slightly. This is accomplished by adding inert substances, substances that are inactive, to the generic alternative. Inert substances may function as disintegrates, binders, fillers, drying agents, lubricants, coatings, wetting agents, flavorings, coloring, or drying agents. Generic drugs are often up to 50 to 80 percent cheaper than their brand name counterpart and are gaining in popularity among cost-conscious consumers and their third-party payers.
Generic drugs enter into the retail prescription industry in a two-step process. The exclusive patent protection for the brand name product must expire. As a brand name product nears patent expiration, generic competitors apply for approval to the FDA using an Abbreviated New Drug Application (ANDA). Duplicating studies of the original brand name drug is no longer required by the FDA, and many generic companies contract with specialty laboratories to conduct the bioequivalency studies regarding absorption rates. Although the majority of products must meet bioequivalence standards, bronchodilators and topical drugs cannot be measured by absorption rates and are exempt. Injectables do not require biostudies, and oral liquids are reviewed on an individual basis. The drug must receive FDA approval following this rigid testing. The FDA also conducts periodic plant site inspections and surveillance of quality control procedures.
Filter your search
Research Assistance
Generics Drugs Industry Research & Market Reports
-
Generic and Biosimilar Pharmaceuticals (GLOBAL) - Industry Report
... BOEHRINGER SOHN AG & CO. KG and TEVA API INDIA PRIVATE LIMITED. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Generic and Biosimilar Pharmaceuticals ... Read More
-
Generic Drugs Markets in China
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More
-
Generic Drugs Industry Forecasts - China Focus
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Generic Drugs Companies in China
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
... treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result, competitive intensity in this segment ... Read More
-
Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2018-2023
... market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the ... Read More
-
GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
... GCC region, the demand for generic drugs has been rising due to the cost-containment measure by the governments stimulated by the unsustainably high spending on healthcare in the region. A large expatriate and low-income population ... Read More
-
Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
... as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D cycle is cheaper and shorter. Unlike branded drug manufacturers who ... Read More
-
Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
... relatively lower penetration in Japan compared to other developed markets such as the United States and Europe. Historically, the lower penetration of generic drugs in japan was due to several reasons. These included – the ... Read More
-
US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
... arthritis, osteoarthritis, osteoporosis, etc. In the United States, these drugs form an important part of the public healthcare system and contribute in significant savings for the patients and healthcare providers. According to IMARC Group’s new ... Read More
-
Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
... and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalysed by a number of factors. The continuous expiration of drug patents, rising aging ... Read More
-
Generic Drugs Market Forecast 2018-2028
... expected to grow at a CAGR of 7.2% in the second half of the forecast period. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging ... Read More
-
High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023
... projected to grow at a CAGR of 8.7%” The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%. The growth in this ... Read More
-
US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
... prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. During 2011-2017, the US generic drug market grew at a CAGR of 13% and currently represents a multibillion ... Read More
-
Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report
... generic manufacturers. Rising use of generic and biosimilar products (drugs developed from living things such as antibodies), has already resulted in trillions of dollars in savings for employers, health plans, patients and the government, according ... Read More
-
Global Generics Industry Profile & Value Chain Analysis
... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. The value chain analysis reveals the business activities which comprise the global generics market value chain. All ... Read More
-
Gastrointestinal Therapeutics Market Analysis Report By Type (Branded, Generics), By Route of Administration, By Application (Ulcerative Colitis, Crohn’s Disease, GERD), By Distribution Channel, And Segment Forecasts, 2018 - 2025
... size is expected to reach USD 65.1 billion by 2025, according to a new report by Grand View Research, Inc., registering a 6.6% CAGR during the forecast period. Growing geriatric population prone to gastrointestinal indications ... Read More
-
2018 United States: Retail Sale of Pharmaceutical Goods In Spec. Stores - Industry Forecast report
... projected industry growth/decline, financial ratios and regional data for the period 2010 through 2019. This industry includes retail sale of pharmaceuticals, medical and orthopaedic goods and perfumery and cosmetic articles. Perry/Hope Partners' reports provide the ... Read More
-
Bio-Pharmaceutical Logistics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
... report predicts the global bio-pharmaceutical logistics market to grow with a CAGR of 7.6% over the forecast period of 2017-2023. The study on bio-pharmaceutical logistics market covers the analysis of the leading geographies such as ... Read More
-
Pharmaceuticals: United States
... of: compounded and biological. Compounded pharmaceutical demand is also segmented by therapeutic class as follows: hormones and related, central nervous system, anti-infective, cardiovascular, respiratory, nutritional, digestive and genito-urinary, and dermatological. To illustrate historical trends, total ... Read More
-
Generics Global Group of Eight (G8) Industry Guide 2017-2021
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the G8 generics market. Includes market ... Read More
-
Generics Global Industry Almanac 2017-2021
... the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical ... Read More
-
Generics Global Industry Guide 2017-2021
... the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical ... Read More
-
Generics Top 5 Emerging Markets Industry Guide 2017-2021
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the emerging five generics market. Includes ... Read More
-
Generics BRIC (Brazil, Russia, India, China) Industry Guide 2017-2021
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the BRIC generics market. Includes market ... Read More
